Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 729598, 10 pages
http://dx.doi.org/10.1155/2011/729598
Review Article

Muscle Plasticity and -Adrenergic Receptors: Adaptive Responses of -Adrenergic Receptor Expression to Muscle Hypertrophy and Atrophy

1Laboratory of Physiological Sciences, Faculty of Human Sciences, Waseda University, 2-579-15 Mikajima, Tokorozawa, Saitama 359-1192, Japan
2Japan Society for the Promotion of Science, 8 Ichiban-cho, Chiyoda-ku, Tokyo 102-8472, Japan
3Department of Natural and Living Sciences, Graduate School of Education, Joetsu University of Education, 1 Yamayashiki, Joetsu, Niigata 943-8512, Japan
4Global COE Doctoral Program, Graduate School of Sport Sciences, Waseda University, 2-579-15 Mikajima, Tokorozawa, Saitama 359-1192, Japan

Received 1 June 2011; Accepted 23 August 2011

Academic Editor: Guy Benian

Copyright © 2011 Shogo Sato et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. S. Kim, R. D. Sainz, P. Molenaar, and R. J. Summers, “Characterization of β1- and β2-adrenoceptors in rat skeletal muscles,” Biochemical Pharmacology, vol. 42, no. 9, pp. 1783–1789, 1991. View at Publisher · View at Google Scholar · View at Scopus
  2. R. S. Williams, M. G. Caron, and K. Daniel, “Skeletal muscle β-adrenergic receptors: variations due to fiber type and training,” American Journal of Physiology, vol. 246, no. 2, part 1, pp. E160–E167, 1984. View at Google Scholar · View at Scopus
  3. J. G. Ryall, P. Gregorevic, D. R. Plant, M. N. Sillence, and G. S. Lynch, “β2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol,” American Journal of Physiology, vol. 283, no. 6, pp. R1386–R1394, 2002. View at Google Scholar · View at Scopus
  4. J. G. Ryall, D. R. Plant, P. Gregorevic, M. N. Sillence, and G. S. Lynch, “β2-agonist administration reverses muscle wasting and improves muscle function in aged rats,” Journal of Physiology, vol. 555, no. 1, pp. 175–188, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. J. G. Burniston, W. A. Clark, L. B. Tan, and D. F. Goldspink, “Dose dependent separation of the hypertrophic and myotoxic effects of the β2 agonist clenbuterol in rat striated muscles,” Muscle and Nerve, vol. 33, no. 5, pp. 655–663, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. J. G. Ryall, M. N. Sillence, and G. S. Lynch, “Systemic administration of β2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses,” British Journal of Pharmacology, vol. 147, no. 6, pp. 587–595, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. S. Sato, S. Nomura, F. Kawano, J. Tanihata, K. Tachiyashiki, and K. Imaizumi, “Effects of the β2-agonist clenbuterol on β1- and β2-adrenoceptor mRNA expressions of rat skeletal and left ventricle muscles,” Journal of Pharmacological Sciences, vol. 107, no. 4, pp. 393–400, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Sato, S. Nomura, F. Kawano, J. Tanihata, K. Tachiyashiki, and K. Imaizumi, “Adaptive effects of the β2-agonist clenbuterol on expression of β2-adrenoceptor mRNA in rat fast-twitch fiber-rich muscles,” Journal of Physiological Sciences, vol. 60, no. 2, pp. 119–127, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. A. R. Gosmanov, J. A. Wong, and D. B. Thomason, “Duality of G protein-coupled mechanisms for β-adrenergic activation of NKCC activity in skeletal muscle,” American Journal of Physiology, vol. 283, no. 4, pp. C1025–C1032, 2002. View at Google Scholar · View at Scopus
  10. S. N. Abramson, M. W. Martin, A. R. Hughes et al., “Interaction of β-adrenergic receptors with the inhibitory guanine nucleotide-binding protein of adenylate cyclase in membranes prepared from cyc-S49 lymphoma cells,” Biochemical Pharmacology, vol. 37, no. 22, pp. 4289–4297, 1988. View at Google Scholar · View at Scopus
  11. C. Communal, W. S. Colucci, and K. Singh, “p38 mitogen-activated protein kinase pathway protects adult rat ventricular myocytes against β-adrenergic receptor-stimulated apoptosis. Evidence for Gi-dependent activation,” Journal of Biological Chemistry, vol. 275, no. 25, pp. 19395–19400, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. Johnson, “Molecular mechanisms of β2-adrenergic receptor function, response, and regulation,” Journal of Allergy and Clinical Immunology, vol. 117, no. 1, pp. 18–24, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. J. G. Krupnick and J. L. Benovic, “The role of receptor kinases and arrestins in G protein-coupled receptor regulation,” Annual Review of Pharmacology and Toxicology, vol. 38, pp. 289–319, 1998. View at Google Scholar · View at Scopus
  14. F. Beitzel, M. N. Sillence, and G. S. Lynch, “β-Adrenoceptor signaling in regenerating skeletal muscle after β-agonist administration,” American Journal of Physiology, vol. 293, no. 4, pp. E932–E940, 2007. View at Publisher · View at Google Scholar · View at PubMed
  15. N. J. Rothwell, M. J. Stock, and D. K. Sudera, “Changes in tissue blood flow and β-receptor density of skeletal muscle in rats treated with the β2-adrenoceptor agonist clenbuterol,” British Journal of Pharmacology, vol. 90, no. 3, pp. 601–607, 1987. View at Google Scholar
  16. H. Huang, C. Gazzola, G. G. Pegg, and M. N. Sillence, “Differential effects of dexamethasone and clenbuterol on rat growth and on β2-adrenoceptors in lung and skeletal muscle,” Journal of Animal Science, vol. 78, no. 3, pp. 604–608, 2000. View at Google Scholar
  17. M. N. Sillence, M. L. Matthews, W. G. Spiers, G. G. Pegg, and D. B. Lindsay, “Effects of clenbuterol, ICI118551 and sotalol on the growth of cardiac and skeletal muscle and on β2-adrenoceptor density in female rats,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 344, no. 4, pp. 449–453, 1991. View at Google Scholar
  18. J. L. Nieto, I. Diaz-Laviada, J. M. Malpartida, I. Galve-Roperh, and A. Haro, “Adaptations of the β-adrenoceptor-adenylyl cyclase system in rat skeletal muscle to endurance physical training,” Pflugers Archiv European Journal of Physiology, vol. 434, no. 6, pp. 809–814, 1997. View at Publisher · View at Google Scholar
  19. P. J. Buckenmeyer, A. H. Goldfarb, J. S. Partilla, M. A. Pineyro, and E. M. Dax, “Endurance training, not acute exercise, differentially alters β-receptors and cyclase in skeletal fiber types,” American Journal of Physiology, vol. 258, no. 1, pp. E71–E77, 1990. View at Google Scholar
  20. S. Sato, K. Shirato, K. Tachiyashiki, and K. Imaizumi, “Synthesized glucocorticoid, dexamethasone regulates the expressions of β2-adrenoceptor and glucocorticoid receptor mRNAs but not proteins in slow-twitch soleus muscle of rats,” Journal of Toxicological Sciences, vol. 36, no. 4, pp. 479–486, 2011. View at Publisher · View at Google Scholar
  21. F. Kawano, J. Tanihata, S. Sato et al., “Effects of dexamethasone on the expression of β1-, β2- and β3-adrenoceptor mRNAs in skeletal and left ventricle muscles in rats,” Journal of Physiological Sciences, vol. 59, no. 5, pp. 383–390, 2009. View at Publisher · View at Google Scholar · View at PubMed
  22. S. Sato, H. Suzuki, H. Tsujimoto, K. Shirato, K. Tachiyashiki, and K. Imaizumi, “Casted-immobilization downregulates glucocorticoid receptor expression in rat slow-twitch muscle,” Life Sciences. in press.
  23. G. S. Lynch and J. G. Ryall, “Role of β-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease,” Physiological Reviews, vol. 88, no. 2, pp. 729–767, 2008. View at Publisher · View at Google Scholar · View at PubMed
  24. J. G. Ryall and G. S. Lynch, “The potential and the pitfalls of β-adrenoceptor agonists for the management of skeletal muscle wasting,” Pharmacology and Therapeutics, vol. 120, no. 3, pp. 219–232, 2008. View at Publisher · View at Google Scholar · View at PubMed
  25. Y. S. Kim and R. D. Sainz, “β-adrenergic agonists and hypertrophy of skeletal muscles,” Life Sciences, vol. 50, no. 6, pp. 397–407, 1992. View at Google Scholar
  26. R. T. Hinkle, K. M. B. Hodge, D. B. Cody, R. J. Sheldon, B. K. Kobilka, and R. J. Isfort, “Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the β2-adrenergic receptor,” Muscle and Nerve, vol. 25, no. 5, pp. 729–734, 2002. View at Publisher · View at Google Scholar · View at PubMed
  27. P. Costelli, C. Garcia-Martinez, M. Llovera et al., “Muscle protein waste in tumor-bearing rats is effectively antagonized by a β2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway,” Journal of Clinical Investigation, vol. 95, no. 5, pp. 2367–2372, 1995. View at Google Scholar
  28. S. Busquets, M. T. Figueras, G. Fuster et al., “Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting,” Cancer Research, vol. 64, no. 18, pp. 6725–6731, 2004. View at Publisher · View at Google Scholar · View at PubMed
  29. L. J. Harcourt, J. D. Schertzer, J. G. Ryall, and G. S. Lynch, “Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue,” Neuromuscular Disorders, vol. 17, no. 1, pp. 47–55, 2007. View at Publisher · View at Google Scholar · View at PubMed
  30. W. O. Kline, F. J. Panaro, H. Yang, and S. C. Bodine, “Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol,” Journal of Applied Physiology, vol. 102, no. 2, pp. 740–747, 2007. View at Publisher · View at Google Scholar · View at PubMed
  31. L. C. C. Navegantes, N. M. Z. Resano, R. H. Migliorini, and C. Kettelhut, “Catecholamines inhibit Ca2+-dependent proteolysis in rat skeletal muscle through β2-adrenoceptors and cAMP,” American Journal of Physiology, vol. 281, no. 3, pp. E449–E454, 2001. View at Google Scholar
  32. H. Shi, C. Zeng, A. Ricome, K. M. Hannon, A. L. Grant, and D. E. Gerrard, “Extracellular signal-regulated kinase pathway is differentially involved in β-agonist-induced hypertrophy in slow and fast muscles,” American Journal of Physiology, vol. 292, no. 5, pp. C1681–C1689, 2007. View at Publisher · View at Google Scholar · View at PubMed
  33. T. Kitaura, N. Tsunekawa, and H. Hatta, “Decreased monocarboxylate transporter 1 in rat soleus and EDL muscles exposed to clenbuterol,” Journal of Applied Physiology, vol. 91, no. 1, pp. 85–90, 2001. View at Google Scholar
  34. L. Stevens, C. Firinga, B. Gohlsch, B. Bastide, Y. Mounier, and D. Pette, “Effects of unweighting and clenbuterol on myosin light and heavy chains in fast and slow muscles of rat,” American Journal of Physiology, vol. 279, no. 5, pp. C1558–C1563, 2000. View at Google Scholar
  35. T. Yimlamai, S. L. Dodd, S. E. Borst, and S. Park, “Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway,” Journal of Applied Physiology, vol. 99, no. 1, pp. 71–80, 2005. View at Publisher · View at Google Scholar · View at PubMed
  36. M. A. Pearen, J. G. Ryall, M. A. Maxwell, N. Ohkura, G. S. Lynch, and G. E. O. Muscat, “The orphan nuclear receptor, NOR-1, is a target of β-adrenergic signaling in skeletal muscle,” Endocrinology, vol. 147, no. 11, pp. 5217–5227, 2006. View at Publisher · View at Google Scholar · View at PubMed
  37. M. A. Pearen, S. A. Myers, S. Raichur, J. G. Ryall, G. S. Lynch, and G. E. O. Muscat, “The orphan nuclear receptor, NOR-1, a target of β-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle,” Endocrinology, vol. 149, no. 6, pp. 2853–2865, 2008. View at Publisher · View at Google Scholar · View at PubMed
  38. E. Kawasaki, F. Hokari, M. Sasaki, A. Sakai, K. Koshinaka, and K. Kawanaka, “The effects of β-adrenergic stimulation and exercise on NR4A3 protein expression in rat skeletal muscle,” Journal of Physiological Sciences, vol. 61, no. 1, pp. 1–11, 2010. View at Publisher · View at Google Scholar · View at PubMed
  39. K. L. Pierce, R. T. Premont, and R. J. Lefkowitz, “Seven-transmembrane receptors,” Nature Reviews Molecular Cell Biology, vol. 3, no. 9, pp. 639–650, 2002. View at Publisher · View at Google Scholar · View at PubMed
  40. A. Claing, S. A. Laporte, M. G. Caron, and R. J. Lefkowitz, “Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and ß-arrestin proteins,” Progress in Neurobiology, vol. 66, no. 2, pp. 61–79, 2002. View at Publisher · View at Google Scholar
  41. C. McCormick, L. Alexandre, J. Thompson, and G. Mutungi, “Clenbuterol and formoterol decrease force production in isolated intact mouse skeletal muscle fiber bundles through a β2-adrenoceptor-independent mechanism,” Journal of Applied Physiology, vol. 109, no. 6, pp. 1716–1727, 2010. View at Publisher · View at Google Scholar · View at PubMed
  42. S. W. Jones, D. J. Baker, and P. L. Greenhaff, “G protein-coupled receptor kinases 2 and 5 are differentially expressed in rat skeletal muscle and remain unchanged following β2-agonist administration,” Experimental Physiology, vol. 88, no. 2, pp. 277–284, 2003. View at Publisher · View at Google Scholar
  43. S. M. DeWire, S. Ahn, R. J. Lefkowitz, and S. K. Shenoy, “β-arrestins and cell signaling,” Annual Review of Physiology, vol. 69, pp. 483–510, 2007. View at Publisher · View at Google Scholar
  44. C. A. C. Moore, S. K. Milano, and J. L. Benovic, “Regulation of receptor trafficking by GRKs and arrestins,” Annual Review of Physiology, vol. 69, pp. 451–482, 2007. View at Publisher · View at Google Scholar · View at PubMed
  45. S. K. Shenoy and R. J. Lefkowitz, “Multifaceted roles of β-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling,” Biochemical Journal, vol. 375, no. 3, pp. 503–515, 2003. View at Publisher · View at Google Scholar · View at PubMed
  46. S. Collins, M. Bouvier, M. A. Bolanowski, M. G. Caron, and R. J. Lefkowitz, “cAMP stimulates transcription of the β2-adrenergic receptor gene in response to short-term agonist exposure,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 13, pp. 4853–4857, 1989. View at Google Scholar
  47. S. Collins, J. Altschmied, O. Herbsman, M. G. Caron, P. L. Mellon, and R. J. Lefkowitz, “A cAMP response element in the β2-adrenergic receptor gene confers transcriptional autoregulation by cAMP,” Journal of Biological Chemistry, vol. 265, no. 31, pp. 19330–19335, 1990. View at Google Scholar
  48. L. E. Cornett, F. C. Hiller, S. E. Jacobi, W. Cao, and D. W. McGraw, “Identification of a glucocorticoid response element in the rat β2-adrenergic receptor gene,” Molecular Pharmacology, vol. 54, no. 6, pp. 1016–1023, 1998. View at Google Scholar
  49. T. Bengtsson, B. Cannon, and J. Nedergaard, “Differential adrenergic regulation of the gene expression of the β-adrenoceptor subtypes β1, β2 and β3 in brown adipocytes,” Biochemical Journal, vol. 347, no. 3, pp. 643–651, 2000. View at Publisher · View at Google Scholar
  50. J. R. Hadcock and C. C. Malbon, “Regulation of β-adrenergic receptors by “permissive” hormones: glucocorticoids increase steady-state levels of receptor mRNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 22, pp. 8415–8419, 1988. View at Google Scholar
  51. J. C. W. Mak, M. Nishikawa, H. Shirasaki, K. Miyayasu, and P. J. Barnes, “Protective effects of a glucocorticoid on downregulation of pulmonary β2-adrenergic receptors in vivo,” Journal of Clinical Investigation, vol. 96, no. 1, pp. 99–106, 1995. View at Google Scholar
  52. J. D. Port, L. Y. Huang, and C. C. Malbon, “β-Adrenergic agonists that down-regulate receptor mRNA up-regulate a M(r) 35,000 protein(s) that selectively binds to β-adrenergic receptor mRNAs,” Journal of Biological Chemistry, vol. 267, no. 33, pp. 24103–24108, 1992. View at Google Scholar
  53. B. G. Tholanikunnel, J. G. Granneman, and C. C. Malbon, “The M(r) 35,000 β-adrenergic receptor mRNA-binding protein binds transcripts of G-protein-linked receptors which undergo agonist-induced destabilization,” Journal of Biological Chemistry, vol. 270, no. 21, pp. 12787–12793, 1995. View at Publisher · View at Google Scholar
  54. A. Pende, K. D. Tremmel, C. T. DeMaria et al., “Regulation of the mRNA-binding protein AUF1 by activation of the β-adrenergic receptor signal transduction pathway,” Journal of Biological Chemistry, vol. 271, no. 14, pp. 8493–8501, 1996. View at Publisher · View at Google Scholar
  55. B. C. Blaxall, A. C. Pellett, S. C. Wu, A. Pende, and J. D. Port, “Purification and characterization of β-adrenergic receptor mRNA-binding proteins,” Journal of Biological Chemistry, vol. 275, no. 6, pp. 4290–4297, 2000. View at Publisher · View at Google Scholar
  56. K. Baar and K. Esser, “Phosphorylation of p70(S6k) correlates with increased skeletal muscle mass following resistance exercise,” American Journal of Physiology, vol. 276, no. 1, pp. C120–C127, 1999. View at Google Scholar
  57. P. A. Tesch and J. Karlsson, “Muscle fiber types and size in trained and untrained muscles of elite athletes,” Journal of Applied Physiology, vol. 59, no. 6, pp. 1716–1720, 1985. View at Google Scholar
  58. T. S. Wong and F. W. Booth, “Sekeletal muscle enlargement with weight-lifting exercise by rats,” Journal of Applied Physiology, vol. 65, no. 2, pp. 950–954, 1988. View at Google Scholar
  59. E. B. Colliander and P. A. Tesch, “Effects of eccentric and concentric muscle actions in resistance training,” Acta Physiologica Scandinavica, vol. 140, no. 1, pp. 31–39, 1990. View at Google Scholar
  60. J. O. Holloszy, “Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle,” Journal of Biological Chemistry, vol. 242, no. 9, pp. 2278–2282, 1967. View at Google Scholar
  61. J. O. Holloszy, L. B. Oscai, I. J. Don, and P. A. Molé, “Mitochondrial citric acid cycle and related enzymes: adaptive response to exercise,” Biochemical and Biophysical Research Communications, vol. 40, no. 6, pp. 1368–1373, 1970. View at Google Scholar
  62. D. Pette and C. Heilmann, “Transformation of morphological, functional and metabolic properties of fast twitch muscle as induced by long term electrical stimulation,” Basic Research in Cardiology, vol. 72, no. 2-3, pp. 247–253, 1977. View at Google Scholar
  63. R. S. Staron, R. S. Hikida, and F. C. Hagerman, “Human skeletal muscle fiber type adaptability to various workloads,” Journal of Histochemistry and Cytochemistry, vol. 32, no. 2, pp. 146–152, 1984. View at Google Scholar
  64. R. Mounier, H. Cavalié, G. Lac, and E. Clottes, “Molecular impact of clenbuterol and isometric strength training on rat EDL muscles,” Pflugers Archiv European Journal of Physiology, vol. 453, no. 4, pp. 497–507, 2007. View at Publisher · View at Google Scholar · View at PubMed
  65. G. S. Lynch, A. Hayes, S. P. Campbell, and D. A. Williams, “Effects of β2-agonist administration and exercise on contractile activation of skeletal muscle fibers,” Journal of Applied Physiology, vol. 81, no. 4, pp. 1610–1618, 1996. View at Google Scholar
  66. S. K. Powers, M. Wade, D. Criswell et al., “Role of beta-adrenergic mechanisms in exercise training-induced metabolic changes in respiratory and locomotor muscle,” International Journal of Sports Medicine, vol. 16, no. 1, pp. 13–18, 1995. View at Google Scholar
  67. C. E. Torgan, G. J. Etgen, J. T. Brozinick Jr., R. E. Wilcox, and J. L. Ivy, “Interaction of aerobic exercise training and clenbuterol: effects on insulin-resistant muscle,” Journal of Applied Physiology, vol. 75, no. 4, pp. 1471–1476, 1993. View at Google Scholar
  68. C. E. Torgan, J. T. Brozinick Jr., E. A. Banks, M. Y. Cortez, R. E. Wilcox, and J. L. Ivy, “Exercise training and clenbuterol reduce insulin resistance of obese Zucker rats,” American Journal of Physiology, vol. 264, no. 3, pp. E373–E379, 1993. View at Google Scholar
  69. S. Miura, K. Kawanaka, Y. Kai et al., “An increase in murine skeletal muscle peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) mRNA in response to exercise is mediated by β-adrenergic receptor activation,” Endocrinology, vol. 148, no. 7, pp. 3441–3448, 2007. View at Publisher · View at Google Scholar · View at PubMed
  70. C. Handschin, J. Rhee, J. Lin, P. T. Tarr, and B. M. Spiegelman, “An autoregulatory loop controls peroxisome proliferator-activated receptor γ coactivator 1α expression in muscle,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 12, pp. 7111–7116, 2003. View at Publisher · View at Google Scholar · View at PubMed
  71. T. Akimoto, S. C. Pohnert, P. Li et al., “Exercise stimulates Pgc-1α transcription in skeletal muscle through activation of the p38 MAPK pathway,” Journal of Biological Chemistry, vol. 280, no. 20, pp. 19587–19593, 2005. View at Publisher · View at Google Scholar · View at PubMed
  72. Z. Wu, P. Puigserver, U. Andersson et al., “Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1,” Cell, vol. 98, no. 1, pp. 115–124, 1999. View at Publisher · View at Google Scholar
  73. J. Barbier, F. Rannou-Bekono, J. Marchais, P. M. Berthon, P. Delamarche, and F. Carré, “Effect of training on β1β2β3 adrenergic and M2 muscarinic receptors in rat heart,” Medicine and Science in Sports and Exercise, vol. 36, no. 6, pp. 949–954, 2004. View at Publisher · View at Google Scholar
  74. R. Stones, A. Natali, R. Billeter, S. Harrison, and E. White, “Voluntary exercise-induced changes in β2-adrenoceptor signalling in rat ventricular myocytes,” Experimental Physiology, vol. 93, no. 9, pp. 1065–1075, 2008. View at Publisher · View at Google Scholar · View at PubMed
  75. J. Ogasawara, M. Sanpei, N. Rahman et al., “β-Adrenergic receptor trafficking by exercise in rat adipocytes: roles of G-protein-coupled receptor kinase-2, β-arrestin-2, and the ubiquitin-proteasome pathway,” FASEB Journal, vol. 20, no. 2, pp. 350–352, 2006. View at Publisher · View at Google Scholar · View at PubMed
  76. T. Kizaki, T. Takemasa, T. Sakurai et al., “Adaptation of macrophages to exercise training improves innate immunity,” Biochemical and Biophysical Research Communications, vol. 372, no. 1, pp. 152–156, 2008. View at Publisher · View at Google Scholar · View at PubMed
  77. W. H. Martin, A. R. Coggan, R. J. Spina, and J. E. Saffitz, “Effects of fiber type and training on β-adrenoceptor density in human skeletal muscle,” American Journal of Physiology, vol. 257, no. 5, pp. E736–E742, 1989. View at Google Scholar
  78. R. P. Farrar, K. A. Monnin, D. E. Fordyce, and T. J. Walters, “Uncoupling of changes in skeletal muscle β-adrenergic receptor density and aerobic capacity during the aging process,” Aging, vol. 9, no. 1-2, pp. 153–158, 1997. View at Google Scholar
  79. N. M. Herrera Jr., A. N. Zimmerman, D. D. Dykstra, and L. V. Thompson, “Clenbuterol in the prevention of muscle atrophy: a study of hindlimb-unweighted rats,” Archives of Physical Medicine and Rehabilitation, vol. 82, no. 7, pp. 930–934, 2001. View at Publisher · View at Google Scholar · View at PubMed
  80. R. J. Zeman, R. Ludemann, and J. D. Etlinger, “Clenbuterol, a β2-agonist, retards atrophy in denervated muscles,” American Journal of Physiology, vol. 252, no. 1, pp. E152–E155, 1987. View at Google Scholar
  81. F. Beitzel, P. Gregorevic, J. G. Ryall, D. R. Plant, M. N. Sillence, and G. S. Lynch, “β2-adrenoceptor agonist fenoterol enhances functional repair of regenerating rat skeletal muscle after injury,” Journal of Applied Physiology, vol. 96, no. 4, pp. 1385–1392, 2004. View at Publisher · View at Google Scholar · View at PubMed
  82. I. J. Smith, N. Alamdari, P. O'Neal, P. Gonnella, Z. Aversa, and P. O. Hasselgren, “Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism,” International Journal of Biochemistry and Cell Biology, vol. 42, no. 5, pp. 701–711, 2010. View at Publisher · View at Google Scholar · View at PubMed
  83. W. Zhao, W. Qin, J. Pan, Y. Wu, W. A. Bauman, and C. Cardozo, “Dependence of dexamethasone-induced Akt/FOXO1 signaling, upregulation of MAFbx, and protein catabolism upon the glucocorticoid receptor,” Biochemical and Biophysical Research Communications, vol. 378, no. 3, pp. 668–672, 2009. View at Publisher · View at Google Scholar · View at PubMed
  84. X. Sun, D. R. Fischer, T. A. Pritts, C. J. Wray, and P. O. Hasselgren, “Expression and binding activity of the glucocorticoid receptor are upregulated in septic muscle,” American Journal of Physiology, vol. 282, no. 2, pp. R509–R518, 2002. View at Google Scholar
  85. M. A. Pellegrino, G. D'Antona, S. Bortolotto et al., “Clenbuterol antagonizes glucocorticoid-induced atrophy and fibre type transformation in mice,” Experimental Physiology, vol. 89, no. 1, pp. 89–100, 2004. View at Publisher · View at Google Scholar